Rapid and sensitive LC-MS-MS method for the simultaneous estimation of alfuzosin and dutasteride in human plasma

Chromatographia

Volumn 69, Issue 1-2, 2009, Pages 9-18

  Gomes, Noel A ^a,b   Pudage, Ashutosh ^b   Joshi, Santosh S ^b   Vaidya, Vikas V ^a   Parekh, Sagar A ^b   Tamhankar, Amod V ^a  

^a UNIVERSITY OF MUMBAI   (India)

^b Accutest Research Laboratories I Pvt Ltd   (India)

Author keywords

Alfuzosin, dutasteride, terazosin and finasteride; Column liquid chromatography mass spectrometry; Multiple reaction monitoring

Indexed keywords

ALFUZOSIN; DUTASTERIDE; FINASTERIDE; TERAZOSIN;

ACCURACY; ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DILUTION; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG ISOLATION; DRUG STABILITY; HUMAN; HUMAN EXPERIMENT; IONIZATION; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETER; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; SINGLE DRUG DOSE; SOLID PHASE EXTRACTION; SPIKE; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS;

EID: 58149477861     PISSN: 00095893     EISSN: 16121112     Source Type: Journal    
DOI: 10.1365/s10337-008-0821-1     Document Type: Article

References (15)

1. PM Manoury JL Binet AP Dumas F Lefevre-Borg I Cavero 1986 J Med Chem 29 1 19 25 10.1021/jm00151a003
2. Dollery C (eds), Therapeutic drugs, 2nd edn. Churchill Livingstone Publication, London, pp A84-A86
3. Sanofi-Aventis, Xatral XL 10 mg: Prescribing Information, Surrey, UK. Sanofi-Aventis (2007) eMC
4. KT McVary 2006 J Urol 175 1 35 42 10.1016/S0022-5347(05)00032-7
5. A Mehik P Alas JC Nickel A Sarpola J Pekka 2003 J Urol 62 3 425 429 10.1016/S0090-4295(03)00466-7
6. SA Kaplan RR Gonazalez E Te Alexis 2007 Eur Urol 51 6 1717 1723 10.1016/j.eururo.2007.01.033
7. P Guinebault M Broquaire C Colafranceschi JP Thenot 1986 J Chromatogr A 353 361 369 10.1016/S0021-9673(01)87106-5
8. H Yao W Jin JY Li 2002 Chin J Pharm Anal 22 2 127 128
9. JL Weisner FC Sutherland GH van Essen HKL Hundt KJ Swart AF Hundt 2003 J Chromatogr B Analyt Technol Biomed Life Sci 788 2 361 368 10.1016/S1570-0232(03) 00064-3
10. PO Gisleskog D Hermann M Hammarlund-Udinaes MO Karlson 1999 Br J Clin Pharmacol 47 1 53 58 10.1046/j.1365-2125.1999.00843.x
11. HC Evans KL Goa 2003 Drugs Aging 20 12 905 916 10.2165/00002512- 200320120-00005
12. GlaxoSmithKline Avodart: Prescribing Information, North Carolina, GlaxoSmithKline (2002)
13. DJ Burinsky JD Williams AD Thornquest Jr SL Sides 2001 J Am Soc Mass Spectrom 12 4 385 398 10.1016/S1044-0305(01)00203-3
14. NVS Ramakrishnan KN Vishwottam S Puran M Koteshwara S Manoj M Santosh 2004 J Chromatogr B Anal Technol Biomed Life Sci 809 1 117 124 10.1016/j.jchromb.2004.06.010
15. Guidance for Industry: Bioanalytical Method Validation, U.S. Department of Health and Human Services, Food and Drug Administration Centre for Drug Evaluation and Research (CDER), Centre for Veterinary Medicine (CVM). May, 2001